CP

Catherine Pagliarulo

Vice President at Alexandria Venture Investments / Alexandria Real Estate Equities

Greater Boston

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Medicinal Chemistry
Chemistry
Research
Biotechnology
Pharmaceutical Industry
Life Sciences
Drug Discovery
Market Research
Problem Solving

Education

Work Experience

Alexandria Real Estate Equities, Inc.

2015

  • Vice President, Life Science

    2021

    Alexandria Venture Investments

  • Principal, Science & Technology

    2019 - 2020

    Alexandria Venture Investments

  • Senior Associate, Science & Technology

    2018 - 2019

    Alexandria Venture Investments

  • Associate, Science & Technology

    2017 - 2017

    Alexandria Venture Investments

  • Senior Research Analyst, Science & Technology

    2015 - 2016

    Alexandria Venture Investments

Myeloid Therapeutics

2019

  • Board Observer

    2019

Cubist Pharmaceuticals

2010 - 2015

  • Research Associate II, Discovery Chemistry

    2010 - 2015

    Medicinal Chemistry: Key contributor to ion channel project: Synthesized analogs for several chemical series; optimized targets for potency, solubility and microsomal stability; proposed new analogs based on data using virtual tools and presented ideas at team meetings. Developed strong understanding of multi-disciplinary drug discovery programs. Business Development Job Rotation Marketing Job Rotation

Schering-Plough Research Institute

2009 - 2009

  • Research Intern, Medicinal Chemistry

    2009 - 2009

Boston College

2008 - 2008

  • Research Assistant, Chemistry Department

    2008 - 2008

    Explored the design and synthesis of anthracene derived phosphine ligands for improvement of asymmetric diboration reactions